Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Current Assets (2018 - 2025)

Exagen (XGN) has disclosed Current Assets for 8 consecutive years, with $48.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Current Assets rose 34.12% year-over-year to $48.9 million, compared with a TTM value of $48.9 million through Dec 2025, up 34.12%, and an annual FY2025 reading of $48.9 million, up 34.12% over the prior year.
  • Current Assets was $48.9 million for Q4 2025 at Exagen, down from $52.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $129.4 million in Q1 2021 and bottomed at $32.5 million in Q1 2025.
  • Average Current Assets over 5 years is $69.3 million, with a median of $51.9 million recorded in 2023.
  • The sharpest move saw Current Assets skyrocketed 69.51% in 2021, then tumbled 41.85% in 2023.
  • Year by year, Current Assets stood at $112.7 million in 2021, then crashed by 35.59% to $72.6 million in 2022, then crashed by 34.11% to $47.8 million in 2023, then decreased by 23.8% to $36.5 million in 2024, then soared by 34.12% to $48.9 million in 2025.
  • Business Quant data shows Current Assets for XGN at $48.9 million in Q4 2025, $52.6 million in Q3 2025, and $51.0 million in Q2 2025.